Cargando…
IgG SARS-CoV-2 Antibodies Persist at Least for 10 Months in Patients on Hemodialysis
Autores principales: | Dudreuilh, Caroline, Roper, Tayeba, Breen, Cormac, Chowdhury, Paramit, Douthwaite, Sam, Kumar, Nicola, Moutzouris, Dimitrios-Anestis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8028697/ https://www.ncbi.nlm.nih.gov/pubmed/33851068 http://dx.doi.org/10.1016/j.ekir.2021.03.900 |
Ejemplares similares
-
Is SARS-CoV-2 Serology Relevant for Hemodialysis Patients With COVID-19?
por: Dudreuilh, Caroline, et al.
Publicado: (2020) -
Delivering Dialysis During the COVID-19 Outbreak: Strategies and Outcomes
por: Roper, Tayeba, et al.
Publicado: (2020) -
De-isolation of COVID-19–positive hemodialysis patients in the outpatient setting: a single-center experience
por: Dudreuilh, Caroline, et al.
Publicado: (2020) -
Unclogging the effects of the Angiojet® thrombectomy system on kidney function: a case report
por: Roper, Tayeba, et al.
Publicado: (2021) -
A young woman with renal colic presenting with urogenital anomaly: a case report
por: Michalakis, Konstantinos, et al.
Publicado: (2009)